Evolution and Adaptation to Caregiver of a Socio-geriatric Evaluation (ESOGER)

Socio-geriatric Evaluation (ESOGER): A Clinical Tool in Telehealth to Fight Against Vulnerable Seniors's Health Alterations and Social Isolation

With the COVID-19 pandemic, elderly people (EP) living at home have seen their health deteriorated, thus increasing their needs in support and care. Indeed, while it was estimated that before the pandemic120 000 unattended living at home EP required care and services (taking bath, access to medication and food, etc.), the number doubled after COVID-19. Therefore, the waiting list for socio-medical services for unattended vulnerable clientele without a family doctor grew from 1300 à 1715 EP in a couple of months during the pandemic. With these numbers, it becomes clear that an intervention is needed. Truly, the Institut National d'Excellence en Santé et Services Sociaux (INESSS) conclude that it was pivotal to first identify the most vulnerable EP and second re-orient them according to their needs. Thus the investigator developed the Évaluation et orientation SOcio-GÉRiatrique (ESOGER) questionnaire available on a secure digital plateform enabling both a rapid evaluation and intervention to asses EP needs and provide the adequate ressources. Investigator's previous research has demonstrated that ESOGER is one of the rare clinical tools of first contact in telehealth while being global, multidimensional, and equitable. For this study, the investigator aims to evaluate the effect of ESOGER on EP physical and mental health, loss of autonomy, social isolation, quality of life and ressources consumption.

Study Overview

• Status: Recruiting
• Conditions: Aging; Social Isolation
• Intervention / Treatment: Other: Recommendations

• Study Type: Interventional
• Enrollment (Estimated): 260
• Phase: Not Applicable

Contacts and Locations

• Study Contact: Name: Olivier Beauchet, MD; Phone Number: 3637 514-340-3540; Email: olivier.beauchet@umontreal.ca

Study Locations

• Canada
  • Quebec
    • Montréal, Quebec, Canada, H3W 1W5
      • Recruiting
      • CRIUGM
      • Contact: Kévin Galéry

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 65 years and older (Older Adult)
• Accepts Healthy Volunteers: No

Description

Inclusion Criteria:

• Aged 65 and more
• Living at home on the territory CIUSSS-Centre-Sud de l'île-de-Montréal (CCSMTL) of Jeanne-Mance
• Brief Geriatric Assessment (BGA) score of 1/14 or more defining a severly to milidly frail health.

Exclusion Criteria:

• Principal address outside of the CCSMTL's Jeanne-Mance territory
• Participate at another clinical trial, to avoid interferences
• Not understand written or spoken French or English, questionnaires are only available in French and English.

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Other
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: Single

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Experimental: Group Intervention; Experimental: Group 1 The intervention group will take the ESOGER questionnaire at month 0 and month 3 ( beginning and end) and receive recommendations following their needs.	Other: Recommendations; Ressources recommendations and interventions curated to the needs of the EP such as refering them to a social activity for socially isolated EP
No Intervention: Group control; The participants will only take the ESOGER questionnaire at month 0 and month 3 without recommendations

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
psychological fraility	Anxiety verbal analogic scale, score from 0= no anxiety to 10= extremly anxious	3 months
Socio-economic characteristics	Presence or not of socio-economic problems (binary questions)	3 months
Participant's Quality of life	Measured by the EQ-5D scale with two parts, scale 1 score from 1= no problem to 5 ( sever health problems) and scale 2 visual analogic scale score from 0= worst possible health to 100= best possible health.	3 months
Autonomy	ADL scale score from 0= very dependent to 6= very independent and IADL scale score 0= not autonomous 4= autonomous.	3 months
COVID-19 symptoms	presence or not of fever, cough, and shortness of breath (binary question)	3 months
Social health	Issues related to medication and food delivery and access to home care. Presence or not of a shortage in food, medication and home care ( binary question)	3 months

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Caregiver burden	Based on Zarit scale, score from 0= no burden to 16= high caregiver burnder	3 months

Collaborators and Investigators

• Sponsor: Centre integre universitaire de sante et de services sociaux du Centre-Sud-de-l'Île-de-Montréal

Study record dates

Study Major Dates

• Study Start (Actual): April 4, 2022
• Primary Completion (Estimated): June 1, 2025
• Study Completion (Estimated): March 1, 2026

Study Registration Dates

• First Submitted: September 21, 2021
• First Submitted That Met QC Criteria: September 29, 2021
• First Posted (Actual): September 30, 2021

Study Record Updates

• Last Update Posted (Estimated): February 23, 2024
• Last Update Submitted That Met QC Criteria: February 22, 2024
• Last Verified: February 1, 2024

More Information

Terms related to this study

• Other Study ID Numbers: 2022-616

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No